J. Adam Best
University of California, San Diego
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. Adam Best.
Nature Immunology | 2011
Cliff Y Yang; J. Adam Best; Jamie Knell; Edward Yang; Alison D Sheridan; Adam K Jesionek; Haiyan S. Li; Richard Rivera; Kristin Camfield Lind; Louise M. D'Cruz; Stephanie S. Watowich; Cornelis Murre; Ananda W. Goldrath
During infection, naive CD8+ T cells differentiate into effector cells, which are armed to eliminate pathogens, and memory cells, which are poised to protect against reinfection. The transcriptional program that regulates terminal differentiation into short-lived effector-memory versus long-lived memory cells is not clearly defined. Through the use of mice expressing reporters for the DNA-binding inhibitors Id2 and Id3, we identified Id3hi precursors of long-lived memory cells before the peak of T cell population expansion or upregulation of cell-surface receptors that indicate memory potential. Deficiency in Id2 or Id3 resulted in loss of distinct CD8+ effector and memory populations, which demonstrated unique roles for these inhibitors of E-protein transcription factors. Furthermore, cytokines altered the expression of Id2 and Id3 differently, which provides insight into how external cues influence gene expression.
Nature Immunology | 2013
J. Adam Best; David A. Blair; Jamie Knell; Edward Yang; Viveka Mayya; Andrew Doedens; Michael L. Dustin; Ananda W. Goldrath
After infection, many factors coordinate the population expansion and differentiation of CD8+ effector and memory T cells. Using data of unparalleled breadth from the Immunological Genome Project, we analyzed the CD8+ T cell transcriptome throughout infection to establish gene-expression signatures and identify putative transcriptional regulators. Notably, we found that the expression of key gene signatures can be used to predict the memory-precursor potential of CD8+ effector cells. Long-lived memory CD8+ cells ultimately expressed a small subset of genes shared by natural killer T and γδ T cells. Although distinct inflammatory milieu and T cell precursor frequencies influenced the differentiation of CD8+ effector and memory populations, core transcriptional signatures were regulated similarly, whether polyclonal or transgenic, and whether responding to bacterial or viral model pathogens. Our results provide insights into the transcriptional regulation that influence memory formation and CD8+ T cell immunity.
Blood | 2008
Mark P. Rubinstein; Nicholas A. Lind; Jared F. Purton; Pauline Filippou; J. Adam Best; Patrick A. McGhee; Charles D. Surh; Ananda W. Goldrath
Although it is known that interleukin-7 (IL-7) and IL-15 influence the survival and turnover of CD8+ T cells, less is known about how these cytokines affect different subsets during the course of the immune response. We find that IL-7 and IL-15 differentially regulate CD8+ T-cell subsets defined by KLRG1 and CD127 expression during the contraction phase of the immune response. The provision of IL-15, or the related cytokine IL-2, during contraction led to the preferential accumulation of KLRG1(hi)CD127(lo) CD8+ T cells, whereas provision of IL-7 instead favored the accumulation of KLRG1(lo)CD127(hi) cells. While IL-7 and IL-15 both induced proliferation of KLRG1(lo) cells, KLRG1(hi) cells exhibited an extraordinarily high level of resistance to cytokine-driven proliferation in vivo despite their dramatic accumulation upon IL-15 administration. These results suggest that IL-15 and IL-2 greatly improve the survival of KLRG1(hi) CD8+ T cells, which are usually destined to perish during contraction, without inducing proliferation. As the availability of IL-15 and IL-2 is enhanced during periods of extended inflammation, our results suggest a mechanism in which a population of cytokine-dependent KLRG1(hi) CD8+ T cells is temporarily retained for improved immunity. Consideration of these findings may aid in the development of immunotherapeutic strategies against infectious disease and cancer.
Nature Immunology | 2015
Ross B Fulton; Sara E. Hamilton; Yan Xing; J. Adam Best; Ananda W. Goldrath; Kristin A. Hogquist; Stephen C. Jameson
The strength with which complexes of self peptide and major histocompatibility complex (MHC) proteins are recognized by the T cell antigen receptor (TCR) dictates the homeostasis of naive CD8+ T cells, but its effect on reactivity to foreign antigens is controversial. As expression of the negative regulator CD5 correlates with self-recognition, we studied CD5lo and CD5hi naive CD8+ T cells. Gene-expression characteristics suggested CD5hi cells were better poised for reactivity and differentiation than were CD5lo cells, and we found that the CD5hi pool also exhibited more efficient clonal recruitment and expansion, as well as enhanced reactivity to inflammatory cues, during the recognition of foreign antigen. However, the recognition of complexes of foreign peptide and MHC was similar for both subsets. Thus, CD8+ T cells with higher self-reactivity dominate the immune response to foreign antigens, with implications for T cell repertoire diversity and autoimmunity.
Nature Communications | 2015
Steven Goossens; Enrico Radaelli; Odile Blanchet; Kaat Durinck; Joni Van der Meulen; Sofie Peirs; Tom Taghon; Cedric Tremblay; Magdaline Costa; Morvarid Farhang Ghahremani; Jelle De Medts; Sonia Bartunkova; Katharina Haigh; Claire Schwab; Natalie Farla; Tim Pieters; Filip Matthijssens; Nadine Van Roy; J. Adam Best; Kim Deswarte; Pieter Bogaert; Catherine L. Carmichael; Adam Samuel Rickard; Santi Suryani; Lauryn S. Bracken; Raed Alserihi; Kirsten Canté-Barrett; Lieven Haenebalcke; Emmanuelle Clappier; Pieter Rondou
Early T-cell precursor leukaemia (ETP-ALL) is a high-risk subtype of human leukaemia that is poorly understood at the molecular level. Here we report translocations targeting the zinc finger E-box-binding transcription factor ZEB2 as a recurrent genetic lesion in immature/ETP-ALL. Using a conditional gain-of-function mouse model, we demonstrate that sustained Zeb2 expression initiates T-cell leukaemia. Moreover, Zeb2-driven mouse leukaemia exhibit some features of the human immature/ETP-ALL gene expression signature, as well as an enhanced leukaemia-initiation potential and activated Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signalling through transcriptional activation of IL7R. This study reveals ZEB2 as an oncogene in the biology of immature/ETP-ALL and paves the way towards pre-clinical studies of novel compounds for the treatment of this aggressive subtype of human T-ALL using our Zeb2-driven mouse model.
Journal of Immunology | 2013
Jamie Knell; J. Adam Best; Nicholas A. Lind; Edward Yang; Louise M. D'Cruz; Ananda W. Goldrath
CD8+ T cells play a crucial role in the clearance of intracellular pathogens through the generation of cytotoxic effector cells that eliminate infected cells and long-lived memory cells that provide enhanced protection against reinfection. We have previously shown that the inhibitor of E protein transcription factors, Id2, is necessary for accumulation of effector and memory CD8+ T cells during infection. In this study, we show that CD8+ T cells lacking Id2 did not generate a robust terminally differentiated killer cell lectin-like receptor G1 (KLRG1)hi effector population, but displayed a cell-surface phenotype and cytokine profile consistent with memory precursors, raising the question as to whether loss of Id2 impairs the differentiation and/or survival of effector memory cells. We found that deletion of Bim rescued Id2-deficient CD8+ cell survival during infection. However, the dramatic reduction in KLRG1hi cells caused by loss of Id2 remained in the absence of Bim, such that Id2/Bim double-deficient cells form an exclusively KLRG1loCD127hi memory precursor population. Thus, we describe a role for Id2 in both the survival and differentiation of normal CD8+ effector and memory populations.
Nature Immunology | 2008
Tracy S P Heng; Michio W. Painter; Kutlu G. Elpek; Veronika Lukacs-Kornek; Nora Mauermann; Shannon J. Turley; Daphne Koller; Francis S. Kim; Amy J. Wagers; Natasha Asinovski; Scott Davis; Marlys S. Fassett; Markus Feuerer; Daniel H.D. Gray; Sokol Haxhinasto; Jonathan A. Hill; Gordon Hyatt; Catherine Laplace; Kristen Leatherbee; Diane Mathis; Christophe Benoist; Radu Jianu; David H. Laidlaw; J. Adam Best; Jamie Knell; Ananda W. Goldrath; Jessica Jarjoura; Joseph C. Sun; Yanan Zhu; Lewis L. Lanier
Nature Immunology | 2012
Natalie A. Bezman; Charles C. Kim; Joseph C. Sun; Gundula Min-Oo; Deborah W. Hendricks; Yosuke Kamimura; J. Adam Best; Ananda W. Goldrath; Lewis L. Lanier
Journal of Cell Biology | 2015
Kyla D. Omilusik; J. Adam Best; Bingfei Yu; Steven Goossens; Alexander Weidemann; Jessica V. Nguyen; Eve Seuntjens; Agata Stryjewska; Christiane Zweier; Rahul Roychoudhuri; Luca Gattinoni; Lynne M. Bird; Yujiro Higashi; Hisato Kondoh; Danny Huylebroeck; Jody J. Haigh; Ananda W. Goldrath
PMC | 2013
Aviv Regev; J. Adam Best; David A. Blair; Jamie Knell; Edward Yang; Viveka Mayya; Andrew Doedens; Michael L. Dustin; Ananda W. Goldrath